Today

Agents

Chat

Arena

Discover

More

App

Avalo Therapeutics price objective cut to $24 from $29

AVTX•2026-11-06

BofA Global Research cut its price objective for Avalo Therapeutics to $24 from $29.

Related News

P

Paylocity Holding Corp: BTIG raises target price to $210 from $200

PCTY•2026-11-06

Alpha Metallurgical posts Q3 net loss on cost pressures

AMR•2026-11-06

BlackRock cuts total voting rights in RWE to 7.12% from 7.16%

BLK•2026-11-06

Microchip Technology: Truist Securities cuts target price to $62 from $90

MCHP•2026-11-06

Firefly Aerospace signs rocket engine deal worth more than $1.3 billion with AST SpaceMobile

ASTS•2026-11-06

Avalo Therapeutics price objective cut to $24 from $29 - AVTX News | Rallies